Quest Diagnostics Inc (NYSE:DGX) Trading Down - Short interest fell by -13.41%

Doris Richards
November 18, 2017

APG Asset Management N.V. now owns 2,683,901 shares of the medical research company's stock valued at $251,320,000 after acquiring an additional 1,635,700 shares in the last quarter. Quest Diagnostics Inc has a one year low of $74.18 and a one year high of $107.22. The stock increased 0.11% or $0.1 on November 17, reaching $93.04. About 52,622 shares traded. CalAtlantic Group Inc (NYSE:CAA) has risen 9.92% since November 18, 2016 and is uptrending. It has underperformed by 3.24% the S&P500.

Investors sentiment increased to 1.2 in Q2 2017. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.47 and a quick ratio of 1.37. It dived, as 38 investors sold Quest Diagnostics Inc shares while 200 reduced holdings. 62 funds opened positions while 138 raised stakes.

Here are some institutional investors who have increased or decreased their stake in (DGX). Manufacturers Life Ins The holds 0.02% or 174,942 shares in its portfolio. Acadian Asset Ltd Co reported 0.72% in Quest Diagnostics Inc (NYSE:DGX). Triangle Securities Wealth Management holds 5,148 shares. De Burlo Gru has invested 1.93% of its portfolio in Quest Diagnostics Inc (NYSE:DGX). Btc Capital Mngmt holds 0.89% in Quest Diagnostics Inc (NYSE:DGX) or 44,352 shares. Mcmillion Mgmt Incorporated invested in 0.15% or 2,000 shares. APG Asset Management N.V. grew its position in Quest Diagnostics by 156.0% in the third quarter. Rhumbline Advisers invested in 0.05% or 278,787 shares. Cantab Cap Prns Llp invested in 25,913 shares. Benjamin F Edwards Inc has 55 shares for 0% of their portfolio. Bancorp Of Montreal Can owns 0.01% invested in Synopsys, Inc. The Company's products are sold through its retail stores and e-commerce Websites within the United States, Canada, Mexico and South Africa, as well as department stores, specialty stores, luxury retailers, value priced retailers, national chains, merchants and catalog retailers. Argus Research initiated Quest Diagnostics Inc (NYSE:DGX) rating on Friday, May 12. The stock of Quest Diagnostics Inc (NYSE:DGX) earned "Buy" rating by Canaccord Genuity on Friday, November 13. Therefore 35% are positive. The firm has "Buy" rating by DA Davidson given on Thursday, August 18. (The) downgraded shares of Quest Diagnostics from a "conviction-buy" rating to a "buy" rating and decreased their price target for the stock from $121.00 to $113.00 in a research report on Tuesday, October 10th.

Among 12 analysts covering CalAtlantic Group (NYSE:CAA), 7 have Buy rating, 0 Sell and 5 Hold. On Thursday, October 19 the stock rating was maintained by Jefferies with "Hold".

Equity analyst Wells Fargo & Company lowered the price target of the stock on October 20 changing the price objective from $88.00 to $86.00 with a "Market Perform" recommendation. The firm has "Neutral" rating by Mizuho given on Friday, October 21. The company presently has a consensus rating of "Hold" and an average price target of $106.18.

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Firm operates through two divisions: homebuilding and financial services. It has a 18.7 P/E ratio. The Diagnostic Information Services business develops and delivers diagnostic testing information and services, providing insights that empower and enable a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers and accountable care organizations (ACOs). Its down 0.05, from 1.04 in 2017Q1. It improved, as 16 investors sold PRLB shares while 51 reduced holdings. 32 funds opened positions while 68 raised stakes. Crestwood Cap Limited Partnership invested 1.68% of its portfolio in Proto Labs Inc (NYSE:PRLB). Trust Of Vermont accumulated 1,425 shares or 0.02% of the stock. Moreover, Thrivent For Lutherans has 0% invested in XO Group Inc (NYSE:XOXO). Piedmont Invest Advsrs Ltd Liability invested in 38,375 shares or 0.09% of the stock. Dynamic Cap Mgmt Limited invested in 0.68% or 27,183 shares. Sterling Capital Mgmt Ltd Liability Co owns 37,902 shares. Huntington Bankshares holds 0% or 1,585 shares. Vanguard Group Inc. now owns 14,029,322 shares of the medical research company's stock worth $1,559,500,000 after buying an additional 525,200 shares in the last quarter. Ameriprise has 266,062 shares. Another trade for 833 shares valued at $53,354 was made by Gawlick Rainer on Thursday, May 18. On October 17 Craig Hallum left the stock rating at "Hold" with a current price target of $100.00. Therefore 71% are positive. XO Group had 9 analyst reports since December 6, 2016 according to SRatingsIntel. The stock has "Outperform" rating by FBR Capital on Wednesday, May 11. The company experienced a fall in short interest of -13.41% as of October 13, 2017 from the last reporting period. The stock has "Buy" rating by Canaccord Genuity on Sunday, June 11. The firm has "Neutral" rating by Credit Suisse given on Tuesday, November 7. The firm has "Sector Perform" rating by RBC Capital Markets given on Friday, January 29. The medical research company reported $1.39 earnings per share for the quarter, beating analysts' consensus estimates of $1.35 by $0.04. DGX's profit will be $190.85 million for 16.60 P/E if the $1.40 EPS becomes a reality. After $0.49 actual EPS reported by Proto Labs Inc for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

Receive News & Ratings for Quest Diagnostics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quest Diagnostics Inc and related companies with our FREE daily email newsletter.

Other reports by Iphone Fresh

Discuss This Article